Real-World Evaluation of Continuous Glucose Monitoring Data in People With Diabetes and End-Stage Renal Disease Receiving Dialysis

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Continuous glucose monitoring is a sensor, which monitors glucose levels continuously throughout the day. In people with diabetes, especially those treated with insulin, this sensor helps guide the amount of treatment (such as insulin) required to maintain glucose within target. In dialysis, the glucose levels and insulin needs can change a lot because of the kidney failure and dialysis treatments. The goal of this observational study is to describe the changes in glucose during and in between dialysis sessions over two weeks by using continuous glucose monitoring. The study will also explore whether there is a relationship between the trend of the glucose and fluid level changes during and in between dialysis treatments. Also, the study will assess whether there is a relationship between glucose levels and several long-term outcomes, such as admissions to the hospital, for up to five years.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:

• Age: ≥18 years (no upper age limit)

• People with insulin-treated diabetes who receive NHS funded continuous glucose monitoring as part of their routine clinical care

• Diabetes duration \> 6 months

• People with end-stage renal disease established on dialysis (maintenance haemodialysis or peritoneal dialysis)

• Ability to give informed consent

Locations
Other Locations
United Kingdom
University Hospitals of Derby and Burton
RECRUITING
Derby
Contact Information
Primary
Emma Wilmot
emma.wilmot@nottingham.ac.uk
0044 1332 258268
Backup
Alexandros Liarakos
alexandros.liarakos1@nhs.net
Time Frame
Start Date: 2024-12-31
Estimated Completion Date: 2031-12
Participants
Target number of participants: 40
Sponsors
Leads: University of Nottingham

This content was sourced from clinicaltrials.gov